In the Philippines, the expanded newborn screening kit costs ₱950 more than the six-disorder kit. That price gap reflects the broader range of conditions screened, an important detail for families weighing the scope of newborn screening and its place in early infant care.

Multiple Choice

The price difference between the expanded NBS kit and the six-disorder kit is how many pesos?

To find the price difference, subtract the cost of the six-disorder kit from the cost of the expanded NBS kit. This shows how much more expensive the expanded kit is. In this case, the calculation yields 950 pesos, so the expanded kit costs 950 pesos more than the six-disorder kit. Remember to always subtract the smaller price from the larger price to get a positive difference.

Newborn Screening, Cost, and the Ethics of Early Detection

A difference of 950 pesos can look like a small line on a hospital bill. For a family welcoming a newborn, though, every added cost deserves a clear explanation. That is especially true when the charge relates to newborn screening: a simple blood test that can help identify certain health conditions before a baby shows signs of illness.

In the pricing comparison discussed here, the expanded newborn screening kit costs 950 pesos more than the six-disorder kit. That figure is the gap between the two prices—not the full cost of either kit. The amount may be easy to calculate, but its meaning is bigger than arithmetic. It connects to what screening can detect, what families can afford, and how health professionals should explain choices with care.

What newborn screening can do

Newborn screening, often shortened to NBS, checks for selected conditions that may not be obvious at birth. A tiny blood sample is usually collected from a baby’s heel and sent to a laboratory for analysis. If a result suggests a possible condition, follow-up testing is needed to confirm it.

That last point matters. A screening result is not the same as a diagnosis. Screening sorts results that may need closer attention; it does not settle every medical question on its own. When a result needs follow-up, timely communication and access to further care can make a real difference.

Some conditions included in screening can affect how a baby processes food, produces hormones, or uses certain substances in the body. Without early identification, health problems may grow before anyone knows why. With early detection, clinicians and families may be able to arrange monitoring or treatment sooner.

The scope of a screening panel varies. A six-disorder kit checks for a defined group of conditions, while an expanded kit checks for a broader group. “Expanded” does not mean that every possible disease is included, nor does it mean that every additional finding will lead to a confirmed diagnosis. It means the screening covers more conditions than the smaller panel.

Why the price gap matters

In the stated comparison, the expanded kit costs 950 pesos more than the six-disorder kit. The difference is found by subtracting the six-disorder kit’s price from the expanded kit’s price. Put plainly, the expanded option adds 950 pesos to the kit cost.

Families still need to know the total bill, since a kit price may not reflect every charge related to screening or follow-up. Prices and coverage can also vary by facility, location, and current health-program arrangements. Asking for an itemized explanation is sensible; it helps parents understand what they are being asked to pay and what services are included.

A few hundred or a thousand pesos can mean different things to different households. For one family, the added amount may be manageable. For another, it may compete with transport costs, medicines, or lost income during a hospital stay. That reality shouldn’t be brushed aside. Access to screening depends not only on which tests exist, but also on whether families can reach and afford them.

At the same time, the price alone cannot show the full value of a screening panel. Families may want to know which conditions are included, what happens if a result is abnormal, and whether follow-up services are available nearby. These details help place the extra cost in context.

A Philippine framework for informed care

In the Philippines, the Newborn Screening Act of 2004, Republic Act No. 9288, established a national framework for newborn screening. The law supports the identification of certain congenital disorders and recognizes the importance of early detection and care. It also places weight on informing parents and guardians about screening and its purpose.

That educational part is not a formality. Parents need information they can understand, especially when a decision involves cost or the scope of testing. Health workers can explain what a panel covers, what a screening result can and cannot tell them, and what steps may follow. Clear language matters more than a stack of technical terms.

Consent and communication are closely linked. A family should have a fair chance to ask questions and understand the service being offered. A hurried explanation at a stressful moment can leave parents unsure whether a test is optional, what the added fee covers, or how results will be shared. Good communication gives people room to make an informed decision without pressure or confusion.

More screening brings more responsibility

Broader screening can identify conditions that a smaller panel does not cover. That may create an opportunity for earlier care. Yet adding more conditions also brings responsibilities: laboratories must produce reliable results, providers must explain findings accurately, and health systems need a route for confirming results and connecting families with care.

A result that raises concern can be frightening. Families may hear unfamiliar medical terms before they know whether their baby has a condition. That is why follow-up systems are essential. A screening program is strongest when it pairs testing with prompt contact, confirmatory assessment, appropriate referral, and support for parents.

Privacy matters, too. A newborn’s health information should be handled with care, shared only as needed for the child’s care and the proper operation of the screening program. These concerns are part of bioethics: the field that considers how health decisions affect people’s rights, welfare, and dignity.

There is also a question of fairness. If a broader panel is available but its added cost puts it beyond reach for some families, access may depend too heavily on income or location. Public health programs can help reduce that divide through clear policies, reliable services, and support for families facing financial barriers. The goal is not simply to offer more tests. It is to make meaningful care reachable.

Questions worth asking

When a facility explains newborn screening, parents may find it helpful to ask:

  • Which conditions does each panel screen for?

  • What is included in the quoted price, and are there separate fees?

  • How will the family be contacted if a result needs follow-up?

  • Where can confirmatory testing and care be arranged?

  • What support is available if the added cost is difficult to manage?

These are reasonable questions, not signs of distrust. They help families understand the service and help providers explain it well. In health care, clarity is part of care.

A small number with a wider meaning

The 950-peso difference between the expanded kit and the six-disorder kit is straightforward: it is the additional amount charged for the expanded option in this comparison. But the decision surrounding that amount involves more than subtraction. It touches on the reach of screening, the limits of test results, household finances, informed consent, and the health system’s ability to provide follow-up.

Newborn screening works best when families receive accurate information and babies can access timely care. A broader panel may offer wider screening, but its value depends on reliable testing and meaningful follow-up—not just the number of conditions listed on a form. When price, purpose, and next steps are explained plainly, parents can make decisions with greater confidence, and the focus stays where it belongs: on the child’s health and well-being.